Dexco Balance Sheet Health
Financial Health criteria checks 2/6
Dexco has a total shareholder equity of R$6.7B and total debt of R$7.1B, which brings its debt-to-equity ratio to 105.8%. Its total assets and total liabilities are R$18.6B and R$11.8B respectively. Dexco's EBIT is R$898.3M making its interest coverage ratio 0.9. It has cash and short-term investments of R$2.2B.
Key information
105.8%
Debt to equity ratio
R$7.12b
Debt
| Interest coverage ratio | 0.9x |
| Cash | R$2.15b |
| Equity | R$6.73b |
| Total liabilities | R$11.84b |
| Total assets | R$18.57b |
Recent financial health updates
Is Dexco (BVMF:DXCO3) A Risky Investment?
Oct 26
Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Jan 04Is Dexco (BVMF:DXCO3) A Risky Investment?
Sep 13Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
May 31We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Feb 13We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Nov 13Recent updates
Is Dexco S.A. (BVMF:DXCO3) Potentially Undervalued?
Dec 20There's Reason For Concern Over Dexco S.A.'s (BVMF:DXCO3) Price
Dec 02Is Dexco (BVMF:DXCO3) A Risky Investment?
Oct 26Analysts Are Updating Their Dexco S.A. (BVMF:DXCO3) Estimates After Its Second-Quarter Results
Aug 10Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Aug 08Returns On Capital At Dexco (BVMF:DXCO3) Have Stalled
Jul 19Earnings Miss: Dexco S.A. Missed EPS And Analysts Are Revising Their Forecasts
May 13Is It Time To Consider Buying Dexco S.A. (BVMF:DXCO3)?
May 04Slowing Rates Of Return At Dexco (BVMF:DXCO3) Leave Little Room For Excitement
Apr 15Dexco's (BVMF:DXCO3) Earnings Might Not Be As Promising As They Seem
Mar 14Dexco S.A.'s (BVMF:DXCO3) Earnings Are Not Doing Enough For Some Investors
Jan 19Dexco (BVMF:DXCO3) Has A Somewhat Strained Balance Sheet
Jan 04At R$7.43, Is Dexco S.A. (BVMF:DXCO3) Worth Looking At Closely?
Dec 04Returns Are Gaining Momentum At Dexco (BVMF:DXCO3)
Oct 08Is Dexco (BVMF:DXCO3) A Risky Investment?
Sep 13Returns At Dexco (BVMF:DXCO3) Are On The Way Up
Jun 22Does Dexco (BVMF:DXCO3) Have A Healthy Balance Sheet?
May 31We Like These Underlying Return On Capital Trends At Dexco (BVMF:DXCO3)
Mar 10We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Feb 13Dexco (BVMF:DXCO3) Might Have The Makings Of A Multi-Bagger
Dec 02We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Nov 13Is Now The Time To Look At Buying Dexco S.A. (BVMF:DXCO3)?
Oct 11Investors Will Want Dexco's (BVMF:DXCO3) Growth In ROCE To Persist
Aug 20We Think Dexco (BVMF:DXCO3) Is Taking Some Risk With Its Debt
Aug 05Is There Now An Opportunity In Dexco S.A. (BVMF:DXCO3)?
Jun 10There's Been No Shortage Of Growth Recently For Dexco's (BVMF:DXCO3) Returns On Capital
May 11Is Dexco (BVMF:DXCO3) Using Too Much Debt?
Apr 27Here's Why I Think Dexco (BVMF:DXCO3) Is An Interesting Stock
Mar 15Why Dexco S.A. (BVMF:DXCO3) Could Be Worth Watching
Feb 24The Return Trends At Dexco (BVMF:DXCO3) Look Promising
Feb 04Here's Why We Think Dexco (BVMF:DXCO3) Is Well Worth Watching
Dec 08These 4 Measures Indicate That Dexco (BVMF:DXCO3) Is Using Debt Safely
Nov 20Dexco (BVMF:DXCO3) Is Doing The Right Things To Multiply Its Share Price
Oct 25Does Dexco (BVMF:DXCO3) Deserve A Spot On Your Watchlist?
Sep 02Duratex (BVMF:DTEX3) Has A Rock Solid Balance Sheet
Aug 18Is It Too Late To Consider Buying Duratex S.A. (BVMF:DTEX3)?
Aug 05Duratex (BVMF:DTEX3) Shareholders Will Want The ROCE Trajectory To Continue
Jul 21Financial Position Analysis
Short Term Liabilities: DXCO3's short term assets (R$5.5B) exceed its short term liabilities (R$3.7B).
Long Term Liabilities: DXCO3's short term assets (R$5.5B) do not cover its long term liabilities (R$8.2B).
Debt to Equity History and Analysis
Debt Level: DXCO3's net debt to equity ratio (73.8%) is considered high.
Reducing Debt: DXCO3's debt to equity ratio has increased from 67.3% to 105.8% over the past 5 years.
Debt Coverage: DXCO3's debt is well covered by operating cash flow (20.8%).
Interest Coverage: DXCO3's interest payments on its debt are not well covered by EBIT (0.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 18:37 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dexco S.A. is covered by 20 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Leonardo Neratika | BofA Global Research |
| Guilherme Rosito | BofA Global Research |
| Thiago Lofiego | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |